SCHEMBL20157962

SCHEMBL20157962

CCc1cc(F)ccc1C(=O)c1ccc(C(Br)Br)cc1Br

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
F2R P25116 2/20 0.37
MAPT P10636 4/20 0.34
PKM P14618 3/20 0.34
RIPK1 Q13546 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
AGBL2 Q5U5Z8 1/20 0.34
DPP4 P27487 1/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
ALDH1A1 P00352 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157803 0.83 CES2 (0.47) HTTCES2CES1KMT2A
SCHEMBL21352048 0.83 LCK (0.38) MAPTSMN1; SMN2HTTALDH1A1MEN1
SCHEMBL21352170 0.81 HPGD (0.43) PKMLMNAALOX15MAPK1CES2
SCHEMBL5188661 0.81 CES2 (0.47) MAPTPKMRIPK1SMN1; SMN2LMNA
SCHEMBL20157850 0.80 MAPT (0.39) F2RMAPTPKMRIPK1SMN1; SMN2
SCHEMBL20157556 0.79 LMNA (0.44) MAPTSMN1; SMN2LMNAHTTKDM4E
SCHEMBL21550083 0.78 KMT2A (0.42) CES2CES1KMT2A
SCHEMBL21564952 0.76 NOTUM (0.47) MAPTSMN1; SMN2LMNAHTTKDM4E
SCHEMBL21362565 0.75 MAPT (0.36) F2RMAPTSMN1; SMN2LMNAHTT
SCHEMBL20157805 0.75 NPC1 (0.35) MAPTSMN1; SMN2LMNAHTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018086605-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF 山东罗欣药业集团股份有限公司 2018-05-17 WO disclosed